Ingrown Nail Treatment
NDC 83299-029, JALAWEF Ingrown Nail Treatment, liquid, from Consilii LLC.
- Product NDC
- 83299-029
- Status
- Listed
- Labeler
- Consilii LLC
- Dosage form
- LIQUID
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M005
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83299-029 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CNIDIUM MONNIERI FRUIT5 g/100mL
- CLOVE OIL6 g/100mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83299-029-01 | 83299002901 | 20 mL in 1 BOTTLE (83299-029-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 83299-029 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83299-029 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83299-029. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.